FSD Pharma Inc

NASDAQ:HUGE
CSE: HUGE
Request Investor Info

FSD Pharma is a specialty biotech pharmaceutical R&D company. FSD Pharma BioSciences, a wholly-owned subsidiary, is focusing on developing multiple applications of the company’s lead compound FSD201, ultra-micronized palmitoylethanolamide (PEA), by down-regulating the cytokines to effectuate an anti-inflammatory response.

Projects
Stories
Presentation
Contact
Management
Financials
FSD Pharma Inc Stock Price Today
FSD Pharma Inc Fundamental Data by TradingView

Company Feed

April 28, 2022

FSD Pharma: Developing Novel Solutions for Brain & Inflammatory Disorders

FSD Pharma (CSE: HUGE, NASDAQ: HUGE) is bringing innovative neuro and inflammatory disorders therapies to millions of patients in need.

This is some text inside of a div block.
FSD Pharma micro-PEA compound
Cannabis
July 23, 2020

FSD Pharma: Developing its PEA Compound to Treat COVID-19

FSD Pharma is a specialty biotech pharmaceutical R&D company. FSD Pharma BioSciences, a wholly-owned subsidiary, is focusing on developing multiple ap …

This is some text inside of a div block.
FSD Pharma compound for COVID-19 treatment
Cannabis
July 7, 2020

FDA Approves FSD Pharma to Submit I.N.D. for Compound to Treat Covid-19 Patients

FSD Pharma is a specialty biotech pharmaceutical R&D company. Further, FSD Pharma BioSciences, a wholly-owned subsidiary, is focused on developing ove …

This is some text inside of a div block.
FSD Pharma human body
Cannabis
June 26, 2020

News Alert: FSD Pharma - FDA Approval to Submit I.N.D. Application for Compound to Treat Covid-19 Patients

FSD Pharma is a specialty biotech pharmaceutical company. FSD Pharma BioSciences, Inc., is a wholly-owned subsidiary. Moreover, it is a specialty biot …

This is some text inside of a div block.
FSD Pharma is focused on developing FDA approved synthetic compounds that address unmet medical needs. Follow their symbol HUGE on the Nasdaq.
Cannabis
February 26, 2020

FSD Pharma: Synthetic Compounds for Unmet Medical Needs

FSD Pharma is focused on developing FDA approved synthetic compounds that address unmet medical needs. In addition, they have a team of experienced he …

This is some text inside of a div block.
FSD Pharma cannabinoid research and development cannabis
Cannabis
August 20, 2019

FSD: Advancing Research and Development

FSD's R&D platform focuses on cannabinoids and their potential for widespread clinical applications. With the acquisition of Prismic Pharmaceuticals, …

This is some text inside of a div block.
New Cannabis Facility 400 million grams of annual cannabis production
Cannabis
April 11, 2019

New Cannabis Facility Means More Cultivation

" FSD Pharma would have three point nine million square feet of facility to produce 400 thousand kg of cannabis year over year. This year we will seek …

This is some text inside of a div block.
Indoor Cannabis Facility
Cannabis
January 9, 2019

HUGE Indoor Cannabis Facility Production- FSD Pharma

FSD Pharma’s stock symbol is HUGE. They’re transforming a former Kraft food plant into one of the world’s largest hydroponic indoor cannabis. Moreover …

This is some text inside of a div block.
Subscribe and receive the investor Info